Medical Imaging Compounds
- API : Hynic-Octreotide
Chemical Structure :
Sequence : HYNIC-D-Phe-Cys-Tyr-D-Trp-Lys-Thr-Cys-Thr-OL
Treatment for : Radiolabeled peptides as kits to detect cancer cells
- API : Hynic-Octreotate
Chemical Structure :
Sequence : HYNIC-D-Phe-Cys-Tyr-D-Trp-Lys-Thr-Cys-Thr-OH
Treatment for : It is providing a new perspective in somatostatin receptor imaging.
- API : Mannose Triflate
Cas No. : 92051 – 23 – 5
Chemical Structure :
Treatment for : It is a radiolabeled pharmaceutical preparation for positron emission tomography.
- API : DOTA-Octreotate
Chemical Structure :
Sequence : DOTA-D-Phe-Cys-Tyr-D-Trp-Lys-Thr-Cys-Thr-OH
Treatment for : It is providing a new perspective in somatostatin receptor imaging
- API: Hynic-PSMA – 11
Chemical Structure :
Treatment for : It is used for detecting metastatic and treatment of prostate cancer.
- API : HBED-PSMA – 11
Chemical Structure :
Treatment for : It is used for detecting metastatic and treatment of prostate cancer.
- API : DOTA-PSMA – 617
Chemical Structure :
Treatment for : It is used for detecting metastatic and treatment of prostate cancer.
- API: Hynic-PSMA – 1007
Chemical Structure :
Treatment for: It is used for detecting metastatic and treatment of prostate cancer.
- API : Pentixafor
Chemical Structure :
Treatment for: Medical Imaging
- API : Hynic-FAPI – 46
Chemical Structure :
Treatment for : It is FAP inhibitors (Fibroblast activation protein), which promotes tumor growth and progression, is overexpressed in cancer-associated fibroblasts of many human epithelial cancers.
- API : Hynic – UBI
Chemical Structure :
Sequence : HYNIC-Thr-Gly-Arg-Ala-Lys-Arg-Arg-Met-Gln-Tyr-Asn-Arg-Arg
Treatment for : Medical Imaging
- API : Hynic-Bombesin
Chemical Structure :
Sequence : HYNIC-GABA-Gln-Trp-Ala-Val-Gly-His-Leu-Met-NH2
Treatment for : It is used as a molecular target for imaging tumors to locate and observe the progress.
- API : Trodat
Cas No. : 189950 – 11 – 6
Chemical Structure :
Treatment for : is a promising new radiopharmaceutical with the potential for routine use as the radiopharmaceutical for dopamine transporters scintigraphy as far as its image quality and daily availability are concerned.